Scarica l'app Stockscreener
2.415
4.61%
0.135
Precedente Chiudi:
$2.28
Aprire:
$2.28
Volume 24 ore:
174.00K
Relative Volume:
0.22
Capitalizzazione di mercato:
$184.21M
Reddito:
$4.72B
Utile/perdita netta:
$-123.85M
Rapporto P/E:
-0.1689
EPS:
-14.2981
Flusso di cassa netto:
$-303.12M
1 W Prestazione:
+15.22%
1M Prestazione:
-1.45%
6M Prestazione:
-82.02%
1 anno Prestazione:
-82.02%
Intervallo 1D:
$2.28
$2.4285
Intervallo di 1 settimana:
$2.055
$2.4285
Portata 52W:
$1.885
$2.71
Accendra Health Inc Stock (ACH) Company Profile
Nome
Accendra Health Inc
Settore
Industria
Telefono
(804) 277-4304
Indirizzo
10900 NUCKOLS ROAD, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
2.41 | 174.28M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corporation
|
867.93 | 106.00B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
316.35 | 61.11B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
212.03 | 49.72B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
74.37 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.30 | 1.95B | 14.85M | -136.07M | 7.23M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Downgrade | UBS | Buy → Neutral |
| 2024-07-19 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-12 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-10-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Ripresa | Citigroup | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-30 | Ripresa | JP Morgan | Underweight |
| 2022-03-23 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Aggiornamento | Goldman | Sell → Buy |
| 2020-12-17 | Aggiornamento | UBS | Neutral → Buy |
| 2020-09-25 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-01-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Downgrade | Goldman | Neutral → Sell |
| 2019-11-15 | Aggiornamento | CLSA | Underperform → Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-10 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-03 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-15 | Aggiornamento | CLSA | Underperform → Outperform |
| 2018-12-14 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Downgrade | Goldman | Buy → Neutral |
| 2018-09-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Downgrade | CLSA | Outperform → Sell |
| 2018-04-10 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Aggiornamento | Goldman | Sell → Neutral |
| 2017-11-02 | Downgrade | HSBC Securities | Buy → Hold |
| 2016-03-24 | Aggiornamento | Goldman | Sell → Neutral |
| 2015-12-07 | Downgrade | Goldman | Neutral → Sell |
| 2015-08-31 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Iniziato | HSBC Securities | Underweight |
| 2009-08-05 | Aggiornamento | Citigroup | Sell → Buy |
| 2008-12-01 | Downgrade | HSBC Securities | Neutral → Underweight |
Mostra tutto
Accendra Health Inc Borsa (ACH) Ultime notizie
Kevin M. Webb reports 5.61% stake in Accendra Health (NASDAQ: ACH) - Stock Titan
Owens & Minor Appoints Colin Bain as Chief Products Officer, Effective March 30, 2026 - marketscreener.com
ACH Stock Price, News & Analysis | Accendra Health - Stock Titan
Vanguard disaggregates holdings; Accendra Health (ACH) listed as 0 shares in amendment - Stock Titan
Accendra Health (ACH) CEO surrenders shares to cover RSU tax obligations - Stock Titan
Accendra Health (ACH) CFO surrenders 11,286 shares for tax withholding - Stock Titan
Accendra Health (ACH) COO surrenders shares for tax withholding, retains stake - Stock Titan
Accendra Health (ACH) EVP uses 9,347 shares to cover tax withholding - Stock Titan
OMI SEC FilingsOwens & Minor 10-K, 10-Q, 8-K Forms - Stock Titan
Tranche Update on Accendra Health, Inc.'s Equity Buyback Plan announced on February 28, 2025. - marketscreener.com
Fitch Maintains Accendra Health's Rating Watches; Withdraws Ratings - marketscreener.com
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
Is the Options Market Signaling a Surge in Accendra Health Shares? - Bitget
OMI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ACH SEC FilingsAccendra Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Accendra Health CFO granted 85,067 restricted shares | ACH Insider Trading - Stock Titan
ACH Technical Analysis & Stock Price Forecast - Intellectia AI
Owens & Minor, Inc. (OMI) Stock Analysis: Is The 94% Potential Upside Worth The Risk? - directorstalkinterviews.com
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ACH) 2026-02-25 - Seeking Alpha
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Accendra Health (ACH) and Travere Therapeutics (TVTX) - The Globe and Mail
MSN Money - MSN
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Q4 2025 Accendra Health Inc Earnings Call Transcript - GuruFocus
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
ACH Financials: Income Statement, Balance Sheet & Cash Flow | Accendra Health Inc - Stock Titan
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
Accendra Health Inc Azioni (ACH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):